J&J says COVID-19 booster shot triggered an antibody surge
Interim data from an early-stage trial supports the push for people to get a second dose of Johnson & Johnson's one-dose COVID-19 vaccine. Boosters won't...
CDC, other officials tout coronavirus vaccines despite rare heart risk to the young
U.S. public-health leaders sought to reassure Americans that COVID-19 shots are safe after reports that a relatively small number of mostly young men had suffered...
Pfizer first to seek full approval for COVID-19 vaccine in U.S.; here's what that would change
Pfizer and its partner BioNTech have asked U.S. regulators for full approval of their COVID-19 vaccine, a milestone in their effort to make the shot...
Biden to order 100 million more J&J doses, boosting supply
President Joe Biden will double the U.S. order of Johnson & Johnson's one-shot vaccine — seeking another 100 million doses — bringing the country's total...
Lilly COVID-19 antibody combo gets U.S. emergency authorization
Eli Lilly's combination antibody drug for COVID-19 was cleared for emergency use by U.S. regulators, providing doctors with a treatment option that is expected to...
Covid drugs from Lilly, Regeneron raise access, timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges,...
Was $1.3 billion cyberattack an act of war? Merck squares off against insurers in case with wide relevance
In a world where a hacker can cause more damage than a gunship, the dispute playing out in a New Jersey courtroom will have far-reaching...